Transcranial photobiomodulation with near-infrared light:a promising therapeutic modality for Alzheimer's disease  

作　　者：Hanli Liu Damir Nizamutdinov Jason H.Huang 

机构地区：[1]Bioengineering Department,the University of Texas at Arlington,Arlington,TX,USA [2]Neurosurgery,Neuroscience Institute,Baylor Scott and White Health,Temple,TX,USA [3]Neurosurgery,College of Medicine,Texas A&M University,Temple,TX,USA

出　　处：《Neural Regeneration Research》2023年第9期1944-1945,共2页中国神经再生研究（英文版）

基　　金：supported in part by the National Institute of Mental Health at the National Institutes of Health under the BRAIN Initiative (RF1MH114285)(to HL)。

摘　　要：Transcranial photobiomodulation(tPBM) is a noninvasive neuromodulation technique that delivers near-infrared(NIR) light with low irradiance(i.e.,power density in mW/cm2) in the wavelength range of 800-1070 nm.Several recently published books or collected literature(Hamblin,2019;GonzalezLima,2021) and papers(Nizamutdinov et al. 2022)offer comprehensive reviews of the mechanism of action and potential clinical translations of tPBM for the treatment of a variety of diseases,including neurodegenerative diseases(Alzheimer’s disease(AD),and Parkinson’s disease),traumatic brain injury.

关 键 词：ALZHEIMER DISEASES 

分 类 号：R749.16[医药卫生—神经病学与精神病学]